1. Home
  2. CODX vs ENLV Comparison

CODX vs ENLV Comparison

Compare CODX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • ENLV
  • Stock Information
  • Founded
  • CODX 2013
  • ENLV 2005
  • Country
  • CODX United States
  • ENLV Israel
  • Employees
  • CODX N/A
  • ENLV N/A
  • Industry
  • CODX Medical/Dental Instruments
  • ENLV Biotechnology: Pharmaceutical Preparations
  • Sector
  • CODX Health Care
  • ENLV Health Care
  • Exchange
  • CODX Nasdaq
  • ENLV Nasdaq
  • Market Cap
  • CODX 23.6M
  • ENLV 27.3M
  • IPO Year
  • CODX 2017
  • ENLV 1995
  • Fundamental
  • Price
  • CODX $0.73
  • ENLV $1.24
  • Analyst Decision
  • CODX Hold
  • ENLV Strong Buy
  • Analyst Count
  • CODX 1
  • ENLV 2
  • Target Price
  • CODX $1.50
  • ENLV $9.50
  • AVG Volume (30 Days)
  • CODX 187.1K
  • ENLV 434.6K
  • Earning Date
  • CODX 11-07-2024
  • ENLV 11-29-2024
  • Dividend Yield
  • CODX N/A
  • ENLV N/A
  • EPS Growth
  • CODX N/A
  • ENLV N/A
  • EPS
  • CODX N/A
  • ENLV N/A
  • Revenue
  • CODX $7,321,012.00
  • ENLV N/A
  • Revenue This Year
  • CODX N/A
  • ENLV N/A
  • Revenue Next Year
  • CODX N/A
  • ENLV N/A
  • P/E Ratio
  • CODX N/A
  • ENLV N/A
  • Revenue Growth
  • CODX 57.16
  • ENLV N/A
  • 52 Week Low
  • CODX $0.70
  • ENLV $0.81
  • 52 Week High
  • CODX $2.23
  • ENLV $4.59
  • Technical
  • Relative Strength Index (RSI)
  • CODX 24.04
  • ENLV 53.08
  • Support Level
  • CODX $0.70
  • ENLV $1.16
  • Resistance Level
  • CODX $0.87
  • ENLV $1.24
  • Average True Range (ATR)
  • CODX 0.06
  • ENLV 0.10
  • MACD
  • CODX -0.00
  • ENLV 0.01
  • Stochastic Oscillator
  • CODX 12.00
  • ENLV 56.68

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: